Qun Li

1.1k total citations
57 papers, 809 citations indexed

About

Qun Li is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Qun Li has authored 57 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 19 papers in Molecular Biology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Qun Li's work include Cancer Immunotherapy and Biomarkers (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Qun Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Qun Li collaborates with scholars based in China, United States and United Kingdom. Qun Li's co-authors include John H. Martin, Qiong Zhou, Amit Kapadia, Mary Kay Harper, Jerome Schaack, Chao‐Yu Chen, Daniel V. LaBarbera, Yong Gao, Takashi Usui and Tsuyoshi Minematsu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Biomaterials.

In The Last Decade

Qun Li

53 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qun Li China 16 312 282 119 111 99 57 809
Linlin Yang China 16 332 1.1× 437 1.5× 74 0.6× 155 1.4× 171 1.7× 79 971
Huifang Huang China 16 627 2.0× 290 1.0× 94 0.8× 133 1.2× 124 1.3× 80 1.1k
Naveed Iqbal United States 9 403 1.3× 488 1.7× 89 0.7× 55 0.5× 168 1.7× 28 1.1k
Amelia L. Parker Australia 12 441 1.4× 222 0.8× 44 0.4× 91 0.8× 112 1.1× 16 815
Maria Berndtsson Sweden 14 462 1.5× 261 0.9× 90 0.8× 74 0.7× 47 0.5× 19 998
Mathew Robson United Kingdom 18 451 1.4× 153 0.5× 111 0.9× 130 1.2× 58 0.6× 30 901
Sifan Yu China 18 519 1.7× 230 0.8× 69 0.6× 150 1.4× 149 1.5× 56 878
James E. Han United States 9 266 0.9× 339 1.2× 72 0.6× 39 0.4× 106 1.1× 27 803
Yu Guo China 18 320 1.0× 272 1.0× 83 0.7× 32 0.3× 79 0.8× 67 843

Countries citing papers authored by Qun Li

Since Specialization
Citations

This map shows the geographic impact of Qun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qun Li more than expected).

Fields of papers citing papers by Qun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qun Li. The network helps show where Qun Li may publish in the future.

Co-authorship network of co-authors of Qun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qun Li. A scholar is included among the top collaborators of Qun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qun Li. Qun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Lin‐Quan, Sai-Lan Liu, Muh‐Hwa Yang, et al.. (2025). GFH018 and Toripalimab Combination Therapy for Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: Results from a Phase Ib/II Study. Clinical Cancer Research. 31(16). 3424–3432.
2.
Zuo, Liping, Guangqi Wang, Qun Li, et al.. (2025). T Cells Dysfunction in Multiple Myeloma. ImmunoTargets and Therapy. Volume 14. 997–1014.
3.
Xu, Shiyao, Hongyuan Wang, Fei Li, et al.. (2025). The Concept and Scope of Resilience Against Infectious Disease Outbreaks. China CDC Weekly. 7(23). 783–789.
4.
Wu, Ke, Xiaoxiao Ge, Jieqing Li, et al.. (2024). Wip1 phosphatase activator QGC-8–52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells. Drug Resistance Updates. 79. 101196–101196. 3 indexed citations
5.
Xue, Junli, Yan Zhang, Xudong Hu, et al.. (2024). Phase I/II safety and preliminary efficacy of PM1022, a bispecific antibody targeting PD-L1 and TIGIT, in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). e14694–e14694. 2 indexed citations
6.
Guo, Ye, Lihua Wu, Yong Li, et al.. (2024). First-in-human phase I/II safety and preliminary efficacy of PM1032, a bispecific antibody targeting CLDN18.2 and 4-1BB, in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2662–2662. 3 indexed citations
7.
8.
9.
10.
Ma, Yuxiang, Yuanyuan Zhao, Yang Zhang, et al.. (2023). Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer. 11(6). e006654–e006654. 34 indexed citations
11.
Li, Qun, Qiongyu Hao, Wei Cao, et al.. (2019). PP2Cδ inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer. Science Advances. 5(10). eaaw8417–eaaw8417. 15 indexed citations
12.
Zhang, Bo, Xi Wang, Qun Li, et al.. (2019). Efficacy of irinotecan-based chemotherapy after exposure to an anti-PD-1 antibody in patients with advanced esophageal squamous cell carcinoma. Chinese Journal of Cancer Research. 31(6). 910–917. 13 indexed citations
13.
Liu, Bo, Yanfang Yang, Hongbin Liu, et al.. (2018). Screening for cytotoxic chemical constituents from Justicia procumbens by HPLC–DAD–ESI–MS and NMR. Chemistry Central Journal. 12(1). 6–6. 16 indexed citations
14.
Li, Qun, Yilei Li, Yanying Wang, et al.. (2016). Quantitative proteomic study of human prostate cancer cells with different metastatic potentials. International Journal of Oncology. 48(4). 1437–1446. 22 indexed citations
15.
Wang, Yanying, Jianxin Jiang, Qun Li, et al.. (2016). KAP1 is overexpressed in hepatocellular carcinoma and its clinical significance. International Journal of Clinical Oncology. 21(5). 927–933. 42 indexed citations
16.
Li, Jie, et al.. (2014). GW25-e1123 EPO prevents apoptosis via JAK2/STAT5 in experimental epilepsy. Journal of the American College of Cardiology. 64(16). C85–C85. 1 indexed citations
17.
18.
Lin, Nan‐Horng, Qun Li, Rodger F. Henry, et al.. (2004). Synthesis of 1H-pyridin-2-one derivatives as potent and selective farnesyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(18). 4603–4606. 10 indexed citations
19.
Hasvold, Lisa, Weibo Wang, Stephen L. Gwaltney, et al.. (2003). Pyridone-Containing farnesyltransferase inhibitors: synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 13(22). 4001–4005. 64 indexed citations
20.
Li, Qun & John H. Martin. (2001). Postnatal development of corticospinal axon terminal morphology in the cat. The Journal of Comparative Neurology. 435(2). 127–141. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linlin Yang Breakdown of academic impact, for papers by Huifang Huang Breakdown of academic impact, for papers by Naveed Iqbal Breakdown of academic impact, for papers by Amelia L. Parker Breakdown of academic impact, for papers by Maria Berndtsson Breakdown of academic impact, for papers by Mathew Robson Breakdown of academic impact, for papers by Sifan Yu Breakdown of academic impact, for papers by James E. Han Breakdown of academic impact, for papers by Yu Guo
Rankless by CCL
2026